Qu Lin

2.1k citations

95 papers · 1.6k indexed · h-index 24

Impact in

Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research

Papers in ⓘ

Hepatology 28
- Hepatocellular Carcinoma Treatment and Prognosis 22
Cancer Research 26
- Cancer, Lipids, and Metabolism 14

Co-authors: Xing Li (40 shared papers)Zhan‐Hong Chen (31 shared papers)Min Dong (37 shared papers)Xiaokun Ma (33 shared papers)Xiangyuan Wu (33 shared papers)Dong‐Hao Wu (24 shared papers)Mingsheng Huang (13 shared papers)Dan‐Yun Ruan (25 shared papers)
Journals: Journal of Clinical Oncology (11 papers)Tumor Biology (8 papers)Oncotarget (4 papers)Journal of Cancer (4 papers)International Journal of Oncology (2 papers)
Partner nations: China United States

In The Last Decade

Qu Lin

86 papers receiving 1.6k citations

Peers

Countries citing papers authored by Qu Lin

Since Specialization

Citations

This map shows the geographic impact of Qu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qu Lin more than expected).

Fields of papers citing papers by Qu Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qu Lin. The network helps show where Qu Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Qu Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Qu Lin Line = papers co-authored together Qu Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma Tumor Biology ·Xing Li, Zhan‐Hong Chen, Yan‐Fang Xing, Tiantian Wang, Dong‐Hao Wu, Jing‐Yun Wen, Jie Chen, Qu Lin, Min Dong, Wei Li, Dan‐Yun Ruan, Ze-Xiao Lin, Xiang-yuan Wu, Xiaokun Ma	2014	91
2	High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma European Journal of Cancer ·Xiang‐Bo Wan, Wei Li, Hao Li, Min Dong, Qu Lin, Xiao-Kun Ma, Pei‐Yu Huang, Jing-Yun Wen, Xing Li, Jie Chen, Dan-Yun Ruan, Ze-Xiao Lin, Zhan‐Hong Chen, Quentin Liu, Xiang-Yuan Wu, Ming‐Huang Hong	2013	89
3	Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma Tumor Biology ·Dong‐Hao Wu, Changchang Jia, Jie Chen, Ze‐Xiao Lin, Dan‐Yun Ruan, Xing Li, Qu Lin, Min‐Dong, Xiaokun Ma, Xiang‐Bo Wan, Na Cheng, Zhan‐Hong Chen, Yan‐Fang Xing, Xiangyuan Wu, Jing‐Yun Wen	2014	77
4	Effects of norspermidine on Pseudomonas aeruginosa biofilm formation and eradication MicrobiologyOpen ·Qu Lin, Pengfei She, Yangxia Wang, Fengxia Liu, Di Zhang, Lihua Chen, Zhen Luo, Huan Xu, Yong Qi, Yong Wu	2016	76
5	Exosome-mediated miRNA delivery promotes liver cancer EMT and metastasis. PubMed ·Qu Lin, Churen Zhou, Mingjun Bai, Duo Zhu, Junwei Chen, Haofan Wang, Mingan Li, Chun Wu, Zhengran Li, Mingsheng Huang	2020	64
6	Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-γ ligands induces apoptosis on human myeloid leukemia cells in vitro Annals of Oncology ·Jia‐Jun Liu, Runqing Huang, Dong-Jun Lin, Jun Peng, Xiangyuan Wu, Qu Lin, Xinliang Pan, Yan Song, M. H. Zhang, Mingxiao Hou, Fuqiang Chen	2005	59
7	Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery International Journal of Oncology ·Mingsheng Huang, Long Wang, Junwei Chen, Mingjun Bai, Churen Zhou, Sujuan Liu, Qu Lin	2016	51
8	Peroxisome proliferator activated receptor-γ ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells Cancer Chemotherapy and Pharmacology ·Jiajun Liu, Huiling Lü, Renwei Huang, Dong-Jun Lin, Xiangyuan Wu, Qu Lin, Xinyao Wu, Jing Zheng, Xianglin Pan, Jun Peng, Yuqin Song, Maohong Zhang, Ming Hou, Feng Chen	2005	44
9	Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer Medical Oncology ·Min Dong, Xiang‐Bo Wan, Zhong Yu Yuan, Wei Li, Xin Fan, Tiantian Wang, Yan Lv, Xing Li, Zhan‐Hong Chen, Jie Chen, Qu Lin, Jing-Yun Wen, Xiao-Kun Ma, Quentin Liu, Xiang Wu	2013	43
10	The Prognostic Value of aspartate aminotransferase to lymphocyte ratio and systemic immune-inflammation index for Overall Survival of Hepatocellular Carcinoma Patients Treated with palliative Treatments Journal of Cancer ·Liyun Zhao, Dongdong Yang, Xiaokun Ma, Mengmeng Liu, Dong‐Hao Wu, Xiaoping Zhang, Dan‐Yun Ruan, Jin-Xiang Lin, Jing‐Yun Wen, Jie Chen, Qu Lin, Min Dong, Jingjing Qi, Peishan Hu, Zhao-Lei Zeng, Zhan‐Hong Chen, Xiangyuan Wu	2019	42
11	Circular RNA circCDK13 suppresses cell proliferation, migration and invasion by modulating the JAK/STAT and PI3K/AKT pathways in liver cancer International Journal of Oncology ·Qu Lin, Yunbiao Ling, Junwei Chen, Churen Zhou, Jie Chen, Xing Li, Mingsheng Huang	2018	40
12	Comparison of long-term effects between intra-arterially delivered ethanol and Gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma World Journal of Gastroenterology ·Mingsheng Huang, Qu Lin, Zaibo Jiang, Kangshun Zhu, Shouhai Guan, Zhengran Li, Hong Shan	2004	39
13	The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor- inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in China Lara D. Veeken ·Meng Xu, Lin Zhong, Xiangyu Deng, Li Li, Ying Wei, Zijun Liao, Q. Li, Wei Qin, Hu Zhou, Yuwen Zhang, Qu Lin, Jing-Wen Huang, Li T, Yunfeng Pan, Yanfeng Wu, O. Jin, Bo Yu, J. Gu	2011	37
14	Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study European Radiology ·Mingsheng Huang, Qu Lin, Haofan Wang, Junwei Chen, Mingjun Bai, Long Wang, Kangshun Zhu, Zaibo Jiang, Shouhai Guan, Zhengran Li, Jiesheng Qian, Mingan Li, Pengfei Pang, Hong Shan	2016	37
15	Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma Tumor Biology ·Xing Li, Zhan‐Hong Chen, Xiaokun Ma, Jie Chen, Dong‐Hao Wu, Qu Lin, Min Dong, Wei Li, Tiantian Wang, Dan‐Yun Ruan, Ze-Xiao Lin, Yan‐Fang Xing, Yun Deng, Xiangyuan Wu, Jin-Yun Wen	2014	35
16	Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer Therapies Journal of Cancer ·Xiurong Cai, Zhan‐Hong Chen, Jie Chen, Xiaokun Ma, Mingjun Bai, Tiantian Wang, Xiangwei Chen, Dong‐Hao Wu, Wei Li, Xing Li, Qu Lin, Jing‐Yun Wen, Dan‐Yun Ruan, Ze‐Xiao Lin, Min Dong, Xiangyuan Wu	2017	35
17	MiR-429 Inhibits Oral Squamous Cell Carcinoma Growth by Targeting ZEB1 Medical Science Monitor ·Qu Lin	2015	33
18	Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma Biomedicine & Pharmacotherapy ·Dong‐Hao Wu, Tiantian Wang, Dan‐Yun Ruan, Xing Li, Zhan‐Hong Chen, Jing‐Yun Wen, Qu Lin, Xiaokun Ma, Xiangyuan Wu, Changchang Jia	2017	32
19	Value of the peripheral blood B-cells subsets in patients with ankylosing spondylitis. PubMed ·Qu Lin, Jieruo Gu, Li T, Fucheng Zhang, Zhiming Lin, Zetao Liao, Qiujing Wei, Shuangyan Cao, Li Li	2009	31
20	Anti-proliferative Effects of Oridonin on SPC-A-1 Cells and its Mechanism of Action Journal of International Medical Research ·Jianjun Liu, RW Huang, Lin Dj, Jun Peng, XY Wu, XL Pan, MQ Li, Qu Lin	2004	29

About Qu Lin

Qu Lin is a scholar working on Hepatology, Cancer Research, Oncology, Epidemiology and Rheumatology, having authored 95 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Cancer, Lipids, and Metabolism (14 papers), Liver Disease Diagnosis and Treatment (14 papers), Inflammatory Biomarkers in Disease Prognosis (10 papers), Hepatitis B Virus Studies (7 papers), Spondyloarthritis Studies and Treatments (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Bioactive Natural Diterpenoids Research (6 papers). The work is most often cited by research in Hepatology (349 citations), Cancer Research (455 citations), Otorhinolaryngology (79 citations), Oncology (416 citations) and Epidemiology (399 citations). Qu Lin has collaborated with scholars based in China and United States. Frequent co-authors include Xing Li, Zhan‐Hong Chen, Min Dong, Xiaokun Ma, Xiangyuan Wu, Dong‐Hao Wu, Mingsheng Huang, Dan‐Yun Ruan, Jing‐Yun Wen and Tiantian Wang. Their work appears in journals such as Journal of Clinical Oncology, Tumor Biology, Oncotarget, Journal of Cancer and International Journal of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact